AC Immune (ACIU) Receivables Refunds (2016 - 2020)
AC Immune (ACIU) reported Receivables Refunds of $22123.1 for Q4 2020, down 68.72% year-over-year from $70726.9 in Q1 2020, and down 68.72% on a QoQ basis from $70726.9 in Q4 2019.
AC Immune (ACIU) has 5 years of Receivables Refunds data on file, last reported at $22123.1 in Q4 2020.
- Quarterly Receivables Refunds fell 68.72% year-over-year to $22123.1 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $22123.1 (down 68.72% YoY) and the FY2020 annual result came in at $21325.7, down 69.74% from the prior year.
- Receivables Refunds fell to $22123.1 in Q4 2020 per ACIU's latest filing, from $70726.9 in the prior quarter.
- Across five years, Receivables Refunds topped out at $116561.6 in Q4 2017 and bottomed at $10048.3 in Q4 2018.
- The 5-year median for Receivables Refunds is $22123.1 (2020), against an average of $46892.1.
- The widest annual swing landed in 2017, when Receivables Refunds soared 677.06%; it then sank 91.38% in 2018.
- Tracing ACIU's Receivables Refunds over 5 years: stood at $15000.4 in 2016, then soared by 677.06% to $116561.6 in 2017, then sank by 91.38% to $10048.3 in 2018, then soared by 603.87% to $70726.9 in 2019, then slumped by 68.72% to $22123.1 in 2020.
- Per Business Quant, the three latest ACIU Receivables Refunds figures stand at $22123.1 (Q4 2020), $70726.9 (Q4 2019), and $10048.3 (Q4 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 22,123.11 |
| Dec 31, 2019 | 70,726.85 |
| Dec 31, 2018 | 10,048.35 |
| Dec 31, 2017 | 116,561.62 |
| Dec 31, 2016 | 15,000.37 |